Results for tag: "Genetic Engineering Tool"

The Genetic Engineering Tool market is a sector within the broader field of genomics that focuses on the development, manufacturing, and distribution of tools and technologies used to manipulate the genetic material of organisms. These tools are fundamental for advancing genomics research as they enable scientists to edit genes, induce mutations, and regulate gene expression. Key technologies within this market include CRISPR-Cas systems, zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and other sequence-specific nucleases, alongside various delivery mechanisms such as viral vectors and lipid nanoparticles. These genetic engineering tools are employed in a multitude of applications including therapeutic development, agricultural biotechnology, and basic research. The conjugation of genetic information with manipulation tools allows for the exploration and potential therapy of genetic diseases, development of genetically modified organisms (GMOs) with desired traits, and the production of synthetic biology products. The market is driven by technological advancements, increasing investment in biotechnology research, and the demand for personalized medicine. Some of the key players in the Genetic Engineering Tool market include Thermo Fisher Scientific, Merck KGaA through its Sigma-Aldrich brand, CRISPR Therapeutics, New England Biolabs, Addgene, Integrated DNA Technologies, and Sangamo Therapeutics. These companies provide a range of products and services that support the different facets of genetic engineering, from gene synthesis and custom RNA/DNA sequencing to gene editing kits and molecular cloning tools. Show Less Read more